VC Mapping Home
Industries
Stages
Countries
Cities
Find investors on Gilion
Industries
AppsAIBiotechFintechSoftwareSaaSMartechLegaltechE-commerce
Countries
DenmarkFinlandFranceGermanySwedenUnited KingdomUnited States
Cities
AmsterdamBerlinBostonCopenhagenLondonLos AngelesMiamiMunichNew YorkParisSan FransiscoSeattleSilicon ValleyStockholm
Investment Stages
Early-StagePre-SeedSeedSeries ASeries B
>
VC Firms
>
Humboldt Fund

Humboldt Fund

Last updated:

April 25, 2025

1899

Founded

22

Investments

United States

Offices

Venture Fund

Investor Type

About the firm

Humboldt Fund is a venture capital firm based in New York, New York, founded in 2020. The firm focuses on investing in early-stage companies within sectors such as food production, healthcare, materials, energy, molecular biology, biomaterials, genetics, mechanical engineering, artificial intelligence, and tissue engineering. Their investment strategy emphasizes supporting innovative startups that address critical global challenges.

Investment Focus

BioTech

Investment Stage

Pre-Seed
Seed
Series A

HQ Locations

United States
New York

Portfolio Companies

Metagenomi, Concerto Biosciences, Theonys, Affini-T, Finless Foods, HAYA Therapeutics, Cellino Biotech, Mission Barns, Minus Coffee, Debut (Discovery Tools)

Gepgraphic Focus

United States, Netherlands, Switzerland, China

Key Differentiators

Focus on early-stage biotech companies, Emphasis on sectors addressing global challenges, Active involvement in portfolio companies

Thypical Investment Size

Up to $10 million.

Total Funds Raised

Not publicly disclosed.

Visit Website

Website

BioTech

New York

Pre-Seed

Seed

Series A

United States